Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | GLI1 | P08151 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | GLI2 | P10070 | 1/20 | 0.36 |
| ▸ | TAS2R46 | P59540 | 4/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TERT | O14746 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | STAT3 | P40763 | 1/20 | 0.31 |
| ▸ | MET | P08581 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2902703 | 1.00 | PTPN1 (0.56) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL2902701 | 1.00 | PTPN1 (0.56) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL2897873 | 0.93 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL1269417 | 0.93 | PTPN1 (0.48) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL1269421 | 0.93 | PTPN1 (0.48) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL316206 | 0.93 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL1269324 | 0.93 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL316207 | 0.93 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL2897875 | 0.93 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA | |
| SCHEMBL10530208 | 0.93 | PTPN1 (0.54) | PTPN1MEN1KMT2ACNR2PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1838653-B1 | NOVEL TRIMETHYLCYCLODODECATRIENE DERIVATIVES, USE THEREOF, AND PERFUMED PRODUCTS CONTAINING THE SAME | MANE FILS V (FR) | 2010-08-04 | — | — | EP | claimed |
| US-20080139446-A1 | Novel Trimethylcyclodoecatriene Derivatives, Use Thereof And Perfumed Products Containing The Same | V. MANE FILS (FR) | 2008-06-12 | — | — | US | claimed |
| EP-1838653-A1 | NOVEL TRIMETHYLCYCLODODECATRIENE DERIVATIVES, USE THEREOF, AND PERFUMED PRODUCTS CONTAINING THE SAME | V. Mane Fils (FR) | 2007-10-03 | — | — | EP | claimed |
| WO-2006077306-A1 | NOVEL TRIMETHYLCYCLODODECATRIENE DERIVATIVES, USE THEREOF, AND PERFUMED PRODUCTS CONTAINING THE SAME | V. MANE FILS (FR) | 2006-07-27 | — | — | WO | claimed |
| JP-57059826-A | — | — | None | — | — | JP | disclosed |
| US-8759280-B2 | Method for producing trimethylcyclododecatriene | EVONIK DEGUSSA GMBH (DE) | 2014-06-24 | — | — | US | disclosed |
| EP-1838653-B1 | NOVEL TRIMETHYLCYCLODODECATRIENE DERIVATIVES, USE THEREOF, AND PERFUMED PRODUCTS CONTAINING THE SAME | MANE FILS V (FR) | 2010-08-04 | — | — | EP | disclosed |
| US-7737107-B2 | Trimethylcyclododecatriene derivatives, use thereof and perfumed products containing the same | Fils, V. Mane (FR) | 2010-06-15 | — | — | US | disclosed |
| US-20090099059-A1 | METHOD FOR PRODUCING TRIMETHYLCYCLODODECATRIENE | DEGUSSA GMBH (DE) | 2009-04-16 | — | — | US | disclosed |
| US-7511110-B2 | Crosslinkable polyorganosiloxane compositions | WACKER CHEMIE AG (DE) | 2009-03-31 | — | — | US | disclosed |
| US-20080139446-A1 | Novel Trimethylcyclodoecatriene Derivatives, Use Thereof And Perfumed Products Containing The Same | V. MANE FILS (FR) | 2008-06-12 | — | — | US | disclosed |
| US-7385000-B2 | Silicone rubber composition having improved storage stability | WACKER CHEMIE AG (DE) | 2008-06-10 | — | — | US | disclosed |
| US-6359098-B1 | SHELF LIFE AS ONE-COMPONENT ADDITION-CURABLE ORGANOPOLYSILOXANES, AND EXTENDED POT LIFE FOR TWO-COMPONENT ADDITION-CURABLE ORGANOPOLYSILOXANES, WITHOUT COMPROMISING CROSSLINKING RATES OR LEVELS | WACKER-CHEMIE GMBH (DE) | 2002-03-19 | — | — | US | disclosed |
| EP-0302993-B1 | METHYLCYCLODODECATRIEN-1-OLS, METHOD FOR THEIR PRODUCTION AND THEIR APPLICATION | HAARMANN & REIMER GMBH (DE) | 1992-05-06 | — | — | EP | disclosed |
| US-4853368-A | Methylcyclododecatri-2,5,9-en-1-ols, a process for their preparation, and their use | HAARMANN & REIMER GMBH (DE) | 1989-08-01 | — | — | US | disclosed |
| EP-0302993-A1 | Methylcyclododecatrien-1-ols, method for their production and their application | HAARMANN & REIMER GMBH (DE) | 1989-02-15 | — | — | EP | disclosed |
| US-4460498-A | Unsaturated alicyclic ethers and their utilization as perfuming and flavoring ingredients | FIRMENICH SA (CH) | 1984-07-17 | — | — | US | disclosed |
| US-4396781-A | PERFUMES, FLAVORS | FIRMENICH SA (CH) | 1983-08-02 | — | — | US | disclosed |
| JP-S5759826-A | PREPARATION OF AROMATIC OILY SUBSTANCE COMPOSED MAINLY OF TRIMETHYLCYCLODODECADIENE CARBALDEHYDE | MITSUBISHI PETROCHEM CO LTD | 1982-04-10 | — | — | JP | disclosed |
| US-3723478-A | MONOEPOXIDIZED PRODUCTS OF DODECATRIENE | FIRMENICH & CIE | 1973-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139446-A1 | Novel Trimethylcyclodoecatriene Derivatives, Use Thereof And Perfumed Products Containing The Same | CBR3, C5, OXER1 | PTPN1 4818/4885MEN1 2707/4885KMT2A 2176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.